Recent technological developments have led to widespread applications of large-scale transcriptomics-based sequencing methods to identify genotype-to-cell type associations. Here we describe a fluorescence-activated cell sorting (FACS)-based sequencing method to utilize CRISPR/Cas9 edited mosaic cerebral organoids to identify or validate genotype-to-cell type associations. Our approach is high-throughput and quantitative and uses internal controls to enable comparisons of the results across different antibody markers and experiments.
Keywords: Cerebral organoids; FACS; Genotype to cell type; Sequencing; oFlowSeq.
© 2023. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.